SavedAdd your journal

Journals / Anadolu Kardiyoloji Dergisi / 2013 / Cilt: 13 - Sayı: 4

Koroner arter hastalığı riskini belirlemede yeni bir index (CHOLINDEX)

A new index (CHOLINDEX) in detecting coronary artery disease risk

Onur AKPINAR
Abdi BOZKURT
Gülşah ŞEYDAOĞLU
Esmeray ACARTÜRK
Pages
315–319
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: CHOLINDEX is a simple index which can be used reliably in prediction of CAD like other lipid parameters in daily clinical practice.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Coronary artery disease (CAD) risk increases with the elevation of low-density lipoprotein cholesterol (LDL-C), triglyceride (TG) and low level high-density lipoprotein cholesterol (HDL-C) levels.
📊
Key Findings & Data:However, the magnitude at which CAD risk increases with every lipid parameter is controversial.
💡
Conclusion & Impact:Conclusion: CHOLINDEX is a simple index which can be used reliably in prediction of CAD like other lipid parameters in daily clinical practice.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Coronary artery disease (CAD) risk increases with the elevation of low-density lipoprotein cholesterol (LDL-C), triglyceride (TG) and low level high-density lipoprotein cholesterol (HDL-C) levels. However, the magnitude at which CAD risk increases with every lipid parameter is controversial. We developed a new index called CHOLINDEX, in order to evaluate CAD risk, and investigated its reliability. Methods: Three hundred and seven patients (190 males and 117 females, aged between 26-80 years, mean 53.6±10.2 years) who underwent diagnostic coronary angiography were included in the study. Risk factors and lipid profiles of all patients were noted. CHOLINDEX was calcu- lated by using a formula as follows: CHOLINDEX=LDL-C–HDL-C (TG < 400 mg/dL), LDL-C–HDL-C + 1/5 of TG (TG ≥ 400mg/dL). Results: Of the 307 patients, 180 had CAD. We found that age, male gender, hypertension, diabetes mellitus, smoking and CHOLINDEX were independent predictors of CAD. The logistic regression analysis showed that the CHOLINDEX had a much more significant relation with CAD (odds ratio=1.011, 95% CI=1.003-1.019) compared with other lipid parameters. Conclusion: CHOLINDEX is a simple index which can be used reliably in prediction of CAD like other lipid parameters in daily clinical practice.

Özet

Amaç: Düşük yoğunluklu lipoprotein kolesterol (LDL-K), trigliserid (TG) düzeyinin yüksekliği ve yüksek yoğunluklu lipoprotein kolesterol (HDL-K) düze- yinin düşüklüğü koroner arter hastalığı (KAH) riskini artırmaktadır. Ancak bu lipit parametrelerin KAH riskini oluşturmadaki miktarı ise hala tartışma- lıdır. Biz bu çalışmada KAH riskini değerlendirebilmek için geliştirdiğimiz CHOLINDEX ismindeki yeni indeksin güvenilirliğini araştırmayı amaçladık. Yöntemler: Koroner anjiyografisi yapılan 307 hasta (190 erkek ve 117 kadın, yaşları 26-80 yıl arası, ortalama 53.6±10.2 yıl) çalışmaya alındı. Tüm hastaların risk faktörleri ve lipit değerleri kaydedildi. CHOLINDEX aşağıdaki formül kullanılarak hesaplandı: CHOLINDEX=LDL-K–HDL-K (TG

🔖

Cite This Article

AKPINAR, O., BOZKURT, A., ŞEYDAOĞLU, G., ACARTÜRK, E. (2022). Koroner arter hastalığı riskini belirlemede yeni bir index (CHOLINDEX). Anadolu Kardiyoloji Dergisi, Cilt: 13 - Sayı: 4, 315–319. https://ajindex.com/articles/436278

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Kannel WB, Neaton JD, Wentworth D, Thomas HE, Stamler J, Hulley SB, et al. Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Multiple Risk Factor Intervention Trial. Am Heart J 1986
  2. [CrossRef] 2. Castelli WP Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study. JAMA 1986
  3. [CrossRef] 3. Gordon T, Castelli WP Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease: The Framingham Study. Am J Med 1977
  4. [CrossRef] 4. Miller GJ, Miller NE. Plasma-high-density-lipoprotein concentration and development of ischaemic heart disease. Lancet 1977
  5. Castelli WP The triglyceride issue: a view from Framingham. Am Heart J 1986
  6. [CrossRef] 6. Kaukola S, Manninen V, Halonen PI. Serum lipids with special reference to HDL cholesterol and triglycerides in young male survivors of acute myocardial infarction. Acta Med Scand 1980
  7. [CrossRef] 7. Gotto AM, Gorry GA, Thompson JR, Cole JS, Trost R, Yeshurun D, et al. Relationship between plasma lipid concentrations and coronary artery disease in 496 patients. Circulation 1977
  8. [CrossRef] 8. Barbir M, Wile D, Trayner I, Aber VR, Thompson GR. High prevalence of hypertriglyceridaemia and apolipoprotein abnormalities in coronary artery disease. Br Heart J 1988
  9. [CrossRef] 9. Ridker PM, Rifai N, Cook NR, Bradwin G, Buring JE. Non-HDL cholesterol, apolipoprotein A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA 2005
  10. [CrossRef] 10. Cui Y, Blumenthal RS, Flaws JA, Whiteman MK, Langenberg P Bachorik PS, et al. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med 2001
  11. [CrossRef] 11. Chobanian AV, Bakris GL, Cushman WC, Green LA, Izzo JL, Jones DW, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Hypertension 2003
  12. [CrossRef] 12. American Diabetes Association, the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1999
  13. Kannel WB, Dawber TR, Friedman GD, Glennon WE, Mcnamara PM. Risk factors in coronary heart disease.